Wuhan Institute of Biological Products Co., Ltd.
Establishment time : Founded in 2003
website : http://www.whb.com.cn/
Main Product : Biological products, vaccines, and pharmaceuticals
Company Profile
Wuhan Institute of Biological Products Co., Ltd. is a leading biopharmaceutical company in China, specializing in the research, development, and production of vaccines, biological products, and pharmaceuticals. With a history dating back to 2003, the company has grown to become a key player in the healthcare industry, serving both domestic and international markets. With a strong focus on innovation and quality, Wuhan Institute of Biological Products Co., Ltd. continues to strive for excellence in providing safe and effective healthcare solutions to improve the well-being of people worldwide.
Hualan Biological Engineering Inc.
Establishment time : Hualan Biological Engineering Inc. was founded in 1993.
website : www.hualanbio.com
Main Product : Hualan Biological Engineering Inc. mainly produces vaccines and biological products.
Company Profile
Hualan Biological Engineering Inc. is a leading player in the biopharmaceutical industry.
Changchun Institute of Biological Products Co., Ltd.
Establishment time : 1958
website : http://www.cibp.cnbio.com/
Main Product : Vaccines, biological products
Company Profile
Changchun Institute of Biological Products Co., Ltd. is a renowned company specializing in the production of vaccines and biological products. Established in 1958, the company has grown to become a leading manufacturer in the industry with a strong presence in both domestic and international markets. With a large company size and advanced R&D capabilities, CIBP is known for its high-quality products and commitment to public health. Visit their website for more information.
Changchun Zhuoyi Biological Co., Ltd
Company Profile
Changchun Zhuoyi Biological Co., Ltd., located in Shuangyang Economic Development Zone of Changchun City, is a key vaccine manufacturer invested by Zhejiang SelCorning Biotechnology Co., Ltd. in Jilin Province, and a vice chairman unit of Zhejiang Chamber of Commerce in Jilin Province. The company was founded on January 27, 2005. Mr. Feng Xingfu, chairman and general manager of the company, graduated from the Department of Biology, University of Science and Technology of China, and has been engaged in the marketing and enterprise management of biological products since the 1980s. The company has a registered capital of one hundred and one million six hundred and ninety-two thousand seven hundred and eighty-four yuan, covers an area of 41600 square meters, and has the leading vaccine research and development and production capacity in China. Changchun Zhuoyi Biological Co., Ltd. is a new vaccine manufacturer integrating R&D, production and sales. At present, the biological products approved by the company are mainly Rabies Vaccine (Vero cell) for Human Use, Freeze-dried. The company successfully passed the two in one inspection at the end of 2016 and obtained the registration approval and GMP certificate, which was officially put into production in January 2017. The company's existing production workshop covers an area of about 5700 square meters, with a cumulative investment of 400 million yuan. At present, the maximum annual output is 1 million people. The second phase workshop has been completed at the end of 2018, and will be officially produced in 2020. By then, the production capacity can reach 4 million people. The company has nearly 2000 square meters of pilot scale research workshop, advanced equipment such as bioreactor, ultrafiltration system, AKTA purification workstation, fluorescence microscope, etc., which are used for virus culture, improvement of purification system and identification of recombinant protein. The company has maintained close scientific research cooperation with many scientific research institutions at home and abroad. At present, the company is developing a serum rabies vaccine and a broad-spectrum human papillomavirus vaccine jointly developed with the Institute of Basic Medicine of the Chinese Academy of Medical Sciences. It is planned to cooperate with Murdoch Children's Research Institute in Australia to develop the round vaccine project. At the same time, the company also actively explores the path of internationalization. At present, the company has started to register in the Philippines, Pakistan, Cambodia, Bangladesh, Mongolia, Uzbekistan and other countries. It is estimated that the export of finished products in some markets will be realized by 2020. The company's technical cooperation project with Australia is one of the company's many international cooperation projects. The company always adheres to the concept of "standardized management, quality first", and adheres to the core values of "honesty, diligence, innovation, preciseness, learning and happiness", so as to provide high-quality vaccine products to serve the health of the people.
Liaoning Chengda Biotechnology Co., Ltd.
Establishment time : 2005
website : www.chengdabio.com
Main Product : Probiotics, enzymes, feed additives
Company Profile
Liaoning Chengda Biotechnology Co., Ltd. is a leading manufacturer of probiotics, enzymes, and feed additives. Established in 2005, the company has grown to become a key player in the industry, serving markets in China, Southeast Asia, and Europe. With a medium-sized operation, Chengda Bio faces strong competition domestically and is working to expand its presence in international markets. Visit their website at www.chengdabio.com for more information.
Changchun Baike Biotechnology Co., Ltd.
Establishment time : Changchun Baike Biotechnology Co., Ltd. was founded in 2012 and has since become a leading provider of probiotics, enzymes, and feed additives.
website :
Main Product : The company faces strong competition from both domestic and international biotechnology companies in the industry.
Company Profile
Overall, Changchun Baike Biotechnology Co., Ltd. is a reputable and reliable company in the biotechnology industry.
Shenzhen Kangtai Biological Products Co., Ltd.
Establishment time : Shenzhen Kangtai Biological Products Co., Ltd. was founded in May 1992.
website :
Main Product : With over 3,000 employees, Kangtai is one of the largest biopharmaceutical companies in China.
Company Profile
The company is committed to improving public health through the development of safe and effective vaccines.
